Shedir Pharma Group S.p.A. (BIT: SHE)

Shedir Pharma Group Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	55	51	43	54	44	80
Market Cap Growth	-18.34%	20.56%	-20.64%	23.38%	-45.57%	-
Enterprise Value	53	48	34	53	47	94
Last Close Price	4.88	4.52	3.60	4.38	3.37	6.19
PE Ratio	9.30	9.15	7.20	13.69	11.09	28.19
Forward PE	8.87	7.86	7.46	11.89	12.27	10.73
PS Ratio	0.91	0.87	0.80	1.20	1.01	1.58
PB Ratio	1.48	1.42	1.30	1.90	1.62	3.53
P/TBV Ratio	1.38	1.69	1.62	2.31	2.02	4.64
P/FCF Ratio	8.80	-	20.26	5.03	4.45	-
P/OCF Ratio	4.78	85.81	16.84	4.53	4.33	-
PEG Ratio	0.75	0.75	0.75	0.75	0.75	0.66
EV/Sales Ratio	0.87	0.81	0.63	1.18	1.10	1.85
EV/EBITDA Ratio	4.23	4.43	3.29	7.59	7.04	10.84
EV/EBIT Ratio	6.04	5.77	4.08	9.94	8.64	12.49
EV/FCF Ratio	8.37	-	16.08	4.95	4.84	-
Debt / Equity Ratio	0.16	0.24	0.31	0.43	0.61	0.66
Debt / EBITDA Ratio	0.47	0.69	0.91	1.56	2.17	1.59
Debt / FCF Ratio	0.93	-	4.81	1.15	1.68	-
Asset Turnover	1.08	1.05	0.98	0.85	0.86	0.94
Inventory Turnover	2.60	2.76	3.49	2.91	2.30	2.49
Quick Ratio	1.51	1.30	1.94	2.18	2.29	1.19
Current Ratio	2.86	2.90	2.69	2.83	3.24	2.03
Return on Equity (ROE)	17.54%	16.58%	19.46%	14.34%	15.98%	11.66%
Return on Assets (ROA)	9.70%	9.27%	9.48%	6.32%	6.81%	8.68%
Return on Capital (ROIC)	12.91%	11.94%	12.42%	7.95%	8.45%	11.54%
Earnings Yield	10.76%	11.09%	13.90%	7.31%	9.02%	3.55%
FCF Yield	11.37%	-5.85%	4.94%	19.89%	22.45%	-3.82%
Dividend Yield	0.00%	-	4.86%	2.97%	6.53%	-
Payout Ratio	0.00%	35.09%	-	-	-	-
Total Shareholder Return	-	4.86%	2.97%	6.53%	-

Source: S&P Capital IQ. Standard template. Financial Sources.